Hepatic involvement by lymphoproliferative disorders post liver transplantation: PTLD.Int. Survey

Hepatology International

Volumn 5, Issue 3, 2011, Pages 759-766

  Izadi, Morteza ^a   Fazel, Mozhgan ^b   Saadat, Seyed Hasan ^a   Taheri, Saeed ^c  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b International Travel Medicine Center of Iran   (Iran)

^c Dr Taheri Medical Research Group   (Iran)

Author keywords

Allograft involvement; Hepatic; Liver transplantation; PTLD; Review

Indexed keywords

AGE; ALLOTRANSPLANTATION; BONE MARROW DISEASE; EPSTEIN BARR VIRUS; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 80054986441     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-011-9271-1     Document Type: Review

References (55)

1. Penn I, Hammond W, Brettschneider L, Starzl TE. Malignant lymphomas in transplantation patents. Transplant Proc 1969;1(1):106-112
2. Levy M, Backman L, Husberg B, et al. De novo malignancy following liver transplantation: a single-center study. Transplant Proc 1993;25(1 Pt 2):1397-1399 (Pubitemid 23079036)
3. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988;133(1):173-192
4. Stieber AO, Boillot O, Scotti-Foglieni C, et al. The surgical implications of the posttransplant lymphoproliferative disorders. Transplant Proc 1991;23(1 Pt 2):1477-1479
5. Malatack JF, Gartner JC Jr, Urbach AH, Zitelli BJ. Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: a growing concern. J Pediatr 1991;118(5):667-675
6. Renard TH, Andrews WS, Foster ME. Relationship between OKT3 administration, EBV seroconversion, and the lymphoproliferative syndrome in pediatric liver transplant recipients. Transplant Proc 1991;23(1 Pt 2):1473-1476
7. Cox KL, Lawrence-Miyasaki LS, Garcia-Kennedy R, et al. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation 1995;59(4):524-529
8. Khedmat H, Taheri S. Early onset post transplantation lymphoproliferative disorders: analysis of international data from 5 studies. Ann Transplant 2009;14(3):74-77
9. Khedmat H, Taheri S. Late onset post transplantation lymphoproliferative disorders: Analysis of international data from 5 studies. Ann Transplant 2009;14(4):80-85
10. Khedmat H, Alavian S, Taheri S. Significance of Epstein-Barr virus infection in the outcome of renal transplant patients with lymphoproliferative disorders. Ann Transplant 2010;15(2):40-44
11. Khedmat H, Taheri S. Characteristics and prognosis of post-transplant lymphoproliferative disorders within renal allograft: report from the PTLD Int. Survey. Ann Transplant 2010;15(3):80-86
12. Pourfarziani V, Taheri S, Lessan-Pezeshki M, et al. Lymphoma after living donor kidney transplantation: an Iranian multicenter experience. Int Urol Nephrol 2008;40(4):1089-1094
13. Nuckols JD, Baron PW, Stenzel TT, et al. The pathology of liverlocalized post-transplant lymphoproliferative disease: a report of three cases and a review of the literature. Am J Surg Pathol 2000;24(5):733-741 (Pubitemid 30253512)
14. Greif F, Bronsther OL, Van Thiel DH, et al. The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg 1994;219(1):40-45 (Pubitemid 24032235)
15. McDiarmid SV, Jordan S, Kim GS, et al. Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients. Transplantation 1998;66(12):1604-1611 (Pubitemid 29034978)
16. Penn I. De novo cancers in organ allograft recipients. Curr Opin Organ Transplant 1998;3:188-196
17. Craig FE, Gulley ML, Banks PM. Posttransplantation lymphoproliferative disorders. Am J Clin Pathol 1993;99(3):265-276 (Pubitemid 23102721)
18. Egawa H, Inomata Y, Uemoto S, et al. Lymphoproliferative disorders in patients undergoing living-related liver transplantation. Transplant Proc 1998;30(1):136-137 (Pubitemid 28090340)
19. Minello-Franza A, Berjamy F, Bresson-Hadni S, et al. Lymphoproliferative disorders in four orthotopic liver transplant patients. Transplant Proc 1995;27(2):1770-1773
20. Baron PW, Heneghan MA, Suhocki PV, et al. Biliary stricture secondary to donor B-cell lymphoma after orthotopic liver transplantation. Liver Transpl 2001;7(1):62-67 (Pubitemid 32060918)
21. Niedobitek G, Mutimer DJ, Williams A, et al. Epstein-Barr virus infection and malignant lymphomas in liver transplant recipients. Int J Cancer 1997;73(4):514-520 (Pubitemid 28005314)
22. Pitman SD, Huang Q, Zuppan CW, et al. Hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically. Am J Surg Pathol 2006;30(4):470-476 (Pubitemid 43740148)
23. Morovic A, Jaffe ES, Raffeld M, Schrager JA. Metachronous EBV-associated B-cell and T-cell posttransplant lymphoproliferative disorders in a heart transplant recipient. Am J Surg Pathol 2009;33(1):149-154
24. Sevmis S, Pehlivan S, Shabazov R, Karakayali H, Ozcay F, Haberal M. Posttransplant lymphoproliferative disease in pediatric liver transplant recipients. Transplant Proc 2009;41(7):2881-2883
25. Cacciarelli TV, Green M, Jaffe R, et al. Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation 1998;66(8):1047-1052 (Pubitemid 28513385)
26. Kerkar N, Morotti RA, Madan RP, et al. The changing face of post-transplant lymphoproliferative disease in the era of molecular EBV monitoring. Pediatr Transplant 2010;14(4):504-511
27. Allen UD, Farkas G, Hebert D, et al. Risk factors for posttransplant lymphoproliferative disorder in pediatric patients: a case-control study. Pediatr Transplant 2005;9(4):450-455 (Pubitemid 41153264)
28. Dusenbery D, Nalesnik MA, Locker J, Swerdlow SH. Cytologic features of post-transplant lymphoproliferative disorder. Diagn Cytopathol 1997;16(6):489-496 (Pubitemid 27248867)
29. Rohr JC, Wagner HJ, Lauten M, et al. Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease. Pediatr Transplant 2008;12(4):426-431 (Pubitemid 351652070)
30. Gerstenkorn C, Jackson G, Di Franco F, Thomusch O, Talbot D. Outcome of PTLD in renal and liver allograft recipients. Transplant Proc 2001;33(4):2469-2472 (Pubitemid 32830189)
31. Norin S, Kimby E, Ericzon BG, et al. Posttransplant lymphoma - a single-center experience of 500 liver transplantations. Med Oncol 2004;21(3):273-284 (Pubitemid 39469769)
32. Capello D, Cerri M, Muti G, et al. Molecular histogenesis of posttransplantation lymphoproliferative disorders. Blood 2003;102(10):3775-3785 (Pubitemid 37409400)
33. Muti G, Cantoni S, Oreste P, et al. Post-transplant lymphoproliferative disorders: Improved outcome after clinico-pathologically tailored treatment. Haematologica 2002;87(1):67-77 (Pubitemid 34101115)
34. Jain A, Nalesnik M, Reyes J, et al. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg 2002;236(4):429-436 (discussion 36-37).
35. Paraskevas S, Coad JE, Gruessner A, et al. Posttransplant lymphoproliferative disorder in pancreas transplantation: a singlecenter experience. Transplantation 2005;80(5):613-622 (Pubitemid 41377748)
36. Duvoux C, Pageaux GP, Vanlemmens C, et al. Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of480 patients. Transplantation 2002;74(8):1103-1109 (Pubitemid 35216103)
37. Smets F, Vajro P, Cornu G, Reding R, Otte JB, Sokal E. Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation. Transplantation 2000;69(5):982-984 (Pubitemid 30174132)
38. Carpentier L, Tapiero B, Alvarez F, Viau C, Alfieri C. Epstein-Barr virus (EBV) early-antigen serologic testing in conjunction with peripheral blood EBV DNA load as a marker for risk of posttransplantation lymphoproliferative disease. J Infect Dis 2003;188(12):1853-1864 (Pubitemid 38064870)
39. Avolio AW, Agnes S, Barbarino R, et al. Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series. Transplant Proc 2007;39(6):1956-1960 (Pubitemid 47198788)
40. Pourfarziani V, Ramezani MB, Taheri S, Izadi M, Einollahi B. Immunogenicity of pneumococcal vaccination in renal transplant recipients and hemodialysis patients: a comparative controlled trial. Ann Transplant 2008;13(3):43-47
41. Izadi M, Taheri S. Significance of in situ hybridization results for EBV-encoded RNA in post-transplantation lymphoproliferative disorder setting: Report from the PTLD Int Survey. Ann Transplant 2010;15(4):102-109
42. Izadi M, Taheri M. Features. Predictors and Prognosis of Lymphoproliferative Disorders Post Liver Transplantation Regarding Disease Presentation Time: Report from the PTLD Int. Survey. Ann Transplant (accepted).
43. Ali MG, Coakley FV, Hricak H, Bretan PN. Complex posttransplantation abnormalities of renal allografts: evaluation with MR imaging. Radiology 1999;211(1):95-100 (Pubitemid 29161738)
44. Wiwanitkit V. Hepatitis virus infection and Hodgkin's lymphoma: a review of the literature. Hepat Mon 2007;7(4):229-231
45. Cockfield SM. Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis 2001;3(2):70-78 (Pubitemid 32452921)
46. Hanto DW, Frizzera G, Purtilo DT, et al. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res 1981;41(11 Pt 1):4253-4261 (Pubitemid 12201326)
47. Hanto DW, Frizzera G, Gajl-Peczalska KJ, et al. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med 1982;306(15):913-918 (Pubitemid 12148553)
48. Djokic M, Le Beau MM, Swinnen LJ, Smith SM, Rubin CM, Anastasi J, Carlson KM. Post-transplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities. Genes Chromosomes Cancer 2006;45(3):313-318 (Pubitemid 43238481)
49. Sasahara Y, Kawai S, Itano M, et al. Epstein-Barr virus-associated lymphoproliferative disorder after unrelated bone marrow transplantation in a young child with Wiskott-Aldrich syndrome. Pediatr Hematol Oncol 1998;15(4):347-352 (Pubitemid 28299834)
50. Shapiro RS, McClain K, Frizzera G, et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988;71(5):1234-1243
51. Mentzer SJ, Longtine J, Fingeroth J, et al. Immunoblastic lymphoma of donor origin in the allograft after lung transplantation. Transplantation 1996;61(12):1720-1725 (Pubitemid 26242011)
52. Weissmann DJ, Ferry JA, Harris NL, Louis DN, Delmonico F, Spiro I. Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin. Am J Clin Pathol 1995;103(6):748-755
53. Khedmat H, Taheri S. Post transplantation lymphoproliferative disorders in renal vs. simultaneous renal-pancreas allograft recipients: report from PTLD Int. Survey. Saudi J Kidney Dis Transpl (accepted).
54. Khedmat H, Taheri S. Post transplantation lymphoproliferative disorders localizing in the adenotonsillar region: report from the PTLD Int. Survey. Ann Transplant (accepted).
55. Khedmat H, Taheri S. Post transplantation lymphoproliferative disorders localizing in the central nervous system: report from the PTLD Int. Survey. Saudi J Kidney Dis Transpl (accepted).